243 related articles for article (PubMed ID: 17657602)
1. The financing and organization of medical care for patients with end-stage renal disease in Sweden.
Wikström B; Fored M; Eichleay MA; Jacobson SH
Int J Health Care Finance Econ; 2007 Dec; 7(4):269-81. PubMed ID: 17657602
[TBL] [Abstract][Full Text] [Related]
2. The organization and financing of end-stage renal disease in Spain.
Luño J
Int J Health Care Finance Econ; 2007 Dec; 7(4):253-67. PubMed ID: 17602295
[TBL] [Abstract][Full Text] [Related]
3. The organization and financing of dialysis and kidney transplantation services in New Zealand.
Ashton T; Marshall MR
Int J Health Care Finance Econ; 2007 Dec; 7(4):233-52. PubMed ID: 17638073
[TBL] [Abstract][Full Text] [Related]
4. International Study of Health Care Organization and Financing of renal services in England and Wales.
Nicholson T; Roderick P
Int J Health Care Finance Econ; 2007 Dec; 7(4):283-99. PubMed ID: 17653861
[TBL] [Abstract][Full Text] [Related]
5. The organization and financing of kidney dialysis and transplant care in the United States of America.
Hirth RA
Int J Health Care Finance Econ; 2007 Dec; 7(4):301-18. PubMed ID: 17602296
[TBL] [Abstract][Full Text] [Related]
6. International Study of Health Care Organization and Financing for end-stage renal disease in France.
Durand-Zaleski I; Combe C; Lang P
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):171-83. PubMed ID: 17680359
[TBL] [Abstract][Full Text] [Related]
7. End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).
Dor A; Pauly MV; Eichleay MA; Held PJ
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):73-111. PubMed ID: 17653860
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and direct medical costs of end-stage renal disease in patients with type 2 diabetes mellitus in Switzerland for 2001.
Sandoz MS; Ess SM; Keusch GW; Schwenkglenks M; Szucs TD
Swiss Med Wkly; 2004 Aug; 134(31-32):448-58. PubMed ID: 15389348
[TBL] [Abstract][Full Text] [Related]
9. The organization and financing of end-stage renal disease treatment in Japan.
Fukuhara S; Yamazaki C; Hayashino Y; Higashi T; Eichleay MA; Akiba T; Akizawa T; Saito A; Port FK; Kurokawa K
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):217-31. PubMed ID: 17690980
[TBL] [Abstract][Full Text] [Related]
10. International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality.
Pontoriero G; Pozzoni P; Vecchio LD; Locatelli F
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):201-15. PubMed ID: 17641969
[TBL] [Abstract][Full Text] [Related]
11. The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care.
Manns BJ; Mendelssohn DC; Taub KJ
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):149-69. PubMed ID: 17641968
[TBL] [Abstract][Full Text] [Related]
12. Current status of end-stage renal disease care in South Asia.
Jha V
Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
[TBL] [Abstract][Full Text] [Related]
13. International study of health care organization and financing: development of renal replacement therapy in Germany.
Kleophas W; Reichel H
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):185-200. PubMed ID: 17701342
[TBL] [Abstract][Full Text] [Related]
14. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
Prodjosudjadi W
Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
[TBL] [Abstract][Full Text] [Related]
15. Dialysis Care and Dialysis Funding in Asia.
Tang SCW; Yu X; Chen HC; Kashihara N; Park HC; Liew A; Goh BL; Nazareth MGC; Bunnag S; Tan J; Lun V; Lydia A; Sharma SK; Hoque E; Togtokh A; Ghnaimet M; Jha V
Am J Kidney Dis; 2020 May; 75(5):772-781. PubMed ID: 31699518
[TBL] [Abstract][Full Text] [Related]
16. The databases: renal replacement therapy since 1989--the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA).
Zoccali C; Kramer A; Jager K
Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S18-22. PubMed ID: 19996000
[TBL] [Abstract][Full Text] [Related]
17. Current status of chronic kidney disease care in southeast Asia.
Jha V
Semin Nephrol; 2009 Sep; 29(5):487-96. PubMed ID: 19751894
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness studies of renal transplantation.
Karlberg I; Nyberg G
Int J Technol Assess Health Care; 1995; 11(3):611-22. PubMed ID: 7591556
[TBL] [Abstract][Full Text] [Related]
19. End-stage renal care in developing countries: the India experience.
Jha V
Ren Fail; 2004 May; 26(3):201-8. PubMed ID: 15354966
[TBL] [Abstract][Full Text] [Related]
20. [Cost-effectiveness analysis of treatment for end-stage renal disease].
Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
